EXECUTIVE ENGAGEMENTS
POOL
6342
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
1013
Interactions with Platform & by Email
PARTICIPANTS
192
Unique # Participated
VALIDATIONS
41
Responses Validated*
COMPANIES
42
Responses Validated*
* Login for a full stack data experience
DATE
JAN 2022
TABLES
123
PAGES
194
EDITION
8
PRICE
USD 4950
CODE
MCP11647
*Engagement stats are ongoing and dynamic
RESEARCH MODULES
EXECUTIVES
HIGHLIGHTS & REPORT INDEX
Global Drug Eluting Balloons (DEBs) Market to Reach $1.5 Billion by 2026
Amid the COVID-19 crisis, the global market for Drug Eluting Balloons (DEBs) estimated at US$400.1 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2026, growing at a CAGR of 24.1% over the analysis period. Peripheral DEBs, one of the segments analyzed in the report, is projected to record a 25.3% CAGR and reach US$1.4 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Coronary DEBs segment is readjusted to a revised 20.7% CAGR for the next 7-year period.
The U.S. Market is Estimated at $154.8 Million in 2021, While China is Forecast to Reach $258.2 Million by 2026
The Drug Eluting Balloons (DEBs) market in the U.S. is estimated at US$154.8 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$258.2 Million by the year 2026 trailing a CAGR of 23.4% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 21.7% and 20.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.7% CAGR.
SELECT PLAYERS
Acrostak Int. Distr. Sarl; B. Braun Melsungen AG; BARD, A Becton, Dickinson Company; Cardionovum GmbH; Cook Medical, Inc.; Eurocor GmbH; Medtronic PLC; Spectranetics Corporation
SEGMENTS
» End-Use (Cath Labs, Hospitals, Ambulatory Surgery Centers) » Product (Peripheral DEBs, Coronary DEBs)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Peripheral DEBs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Peripheral DEBs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Peripheral DEBs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Coronary DEBs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Coronary DEBs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Coronary DEBs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| USA Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| JAPAN |
| Japan Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| CHINA |
| China Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| FRANCE |
| France Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| GERMANY |
| Germany Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| UK Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral DEBs and Coronary DEBs Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral DEBs and Coronary DEBs for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Cath Labs, Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Cath Labs, Hospitals and Ambulatory Surgery Centers for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 42 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com